BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23055189)

  • 1. ING4 is negatively correlated with microvessel density in colon cancer.
    Lou C; Jiang S; Guo X; Dong XS
    Tumour Biol; 2012 Dec; 33(6):2357-64. PubMed ID: 23055189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density.
    Liu Y; Yu L; Wang Y; Zhang Y; Wang Y; Zhang G
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):647-55. PubMed ID: 22228137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
    Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
    Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
    Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
    Fang F; Luo LB; Tao YM; Wu F; Yang LY
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of ING4 is associated with initiation and progression of lung cancer.
    Wang QS; Li M; Zhang LY; Jin Y; Tong DD; Yu Y; Bai J; Huang Q; Liu FL; Liu A; Lee KY; Fu SB
    Histopathology; 2010 Aug; 57(2):271-81. PubMed ID: 20716169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.
    Li XH; Kikuchi K; Zheng Y; Noguchi A; Takahashi H; Nishida T; Masuda S; Yang XH; Takano Y
    Oral Oncol; 2011 Mar; 47(3):217-23. PubMed ID: 21310648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated expression of inhibitor of growth 4 (ING4) in advanced colorectal cancers: a non-randomized experimental study.
    You Q; Wang XS; Fu SB; Jin XM
    Pathol Oncol Res; 2011 Sep; 17(3):473-7. PubMed ID: 21626442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.
    Shatnawi A; Ayoub NM; Alkhalifa AE
    Clin Breast Cancer; 2021 Aug; 21(4):e319-e331. PubMed ID: 33334698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
    Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells.
    Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Gene Ther; 2011 Mar; 18(3):176-88. PubMed ID: 21052098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.
    Tzouvelekis A; Aidinis V; Harokopos V; Karameris A; Zacharis G; Mikroulis D; Konstantinou F; Steiropoulos P; Sotiriou I; Froudarakis M; Pneumatikos I; Tringidou R; Bouros D
    Respir Res; 2009 Feb; 10(1):14. PubMed ID: 19250543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1.
    Shen JC; Unoki M; Ythier D; Duperray A; Varticovski L; Kumamoto K; Pedeux R; Harris CC
    Cancer Res; 2007 Mar; 67(6):2552-8. PubMed ID: 17363573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
    Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
    Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
    Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of ING4 gene in pancreatic cancers and splice forms of ING4 gene.
    Yıldırım İH; Çakmak EA; Camcı C
    Cell Mol Biol (Noisy-le-grand); 2018 Oct; 64(13):6-9. PubMed ID: 30403588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced ING4 Expression Is Associated with the Malignancy of Human Bladder.
    Wang Y; Wang T; Han Y; Wu H; Zhao W; Tong D; Wei L; Zhong Z; An R; Wang Y
    Urol Int; 2015; 94(4):464-71. PubMed ID: 25790869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor Angiogenesis.
    Xu M; Xie Y; Sheng W; Miao J; Yang J
    Technol Cancer Res Treat; 2015 Oct; 14(5):617-26. PubMed ID: 24750000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ING4 is negatively correlated with cellular proliferation and microvessel density in human glioma.
    Shao B; Liu E
    Oncol Lett; 2017 Sep; 14(3):3663-3668. PubMed ID: 28927128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: Correlations to the clinicopathological parameters.
    Kowalczyk AE; Krazinski BE; Godlewski J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Kiezun J; Wierzbicki PM; Bodek G; Sulik M; Kmiec Z
    Int J Oncol; 2015 Sep; 47(3):951-62. PubMed ID: 26134521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.